We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/7/2018 10:32 | Explains the sells and fall before results: As previously announced in June 2018, we disposed of approximately half of our holding in Summit Therapeutics plc before the announcement of the failure of their clinical trial to meet primary or secondary endpoints. This sale generated GBP118,701.67 net cash to add to our reserves. | waterloo01 | |
17/7/2018 21:50 | Interesting posts by Clarkey26 & waterloo01 & agree that the cost saving RNS is now essential to maintain/improve the share price not helped tonight by the closing NASDAQ at $2.20 = £0.34p. | chrisatrdg | |
17/7/2018 19:13 | Clarkey26, I hope they keep the Nasdaq listing as it's potentially excellent exposure to the US capital markets. Value hunters will eventually out and if Nasdaq drives higher, so will AIM. It's clearly undervalued by almost any metric. The CEO and Chairman clearly see that and as the 'older' biotech hands, they should know. They are also not known to buy shares to prop up the share price Never have before! We have all sorts of news that can drive the share price If someone makes a speculative bid, then that might at anytime. However the share price might well see some pressure as some larger holders exit as they were in it for the larger, riskier prize in DMD (I'm thinking point 72) | waterloo01 | |
17/7/2018 19:01 | We need to see the cost saving news and new structure which will be left that might help the share price if perceived to be good. My main concern is being dragged down by the Nasdaq, difficult enough getting recognised when appeared had as positive DMD candidate although to be fair it did seem to help getting funding. I struggle to see what will drive the Nasdaq interest now. Do we even need it or do we cut USA arm and listing? I think currently AIM would be in more positive territory, maybe NASDAQ falling in anticipation of de-listing. | clarkey26 | |
17/7/2018 08:49 | Dr Frank Armstrong, Summit's Non-Executive Chairman, purchased 25,000 ordinary shares of 1p each in the Company at 39.5 pence per and the share price goes down 5.5% wtf | football | |
17/7/2018 08:44 | Coming on top of the Dir's buying, it will only need a very modest whiff of decent news to lift this to a much better level. I've bought for that future. f | fillipe | |
17/7/2018 07:07 | As I suggested might not be the end of director buying. Frank rarely pulls his wallet out! | waterloo01 | |
16/7/2018 16:01 | This should be much higher even the directors now filling their boots | kirk 6 | |
16/7/2018 14:30 | Well that's a vote of confidence. Wonder if we'll see any further director purchases before they end up in another closed period? They must have a sense of the value here. | waterloo01 | |
16/7/2018 13:20 | Hi All Clearly Summit are not in a closed period & Glyn clearly feels he is here to stay but it is good that he has shown confidence in Summit & it will help bring his average share price down.I am also confident in Summit & increased my holdings by a third the week of the infamous dmd RNS.Onwards & upwards. | chrisatrdg | |
16/7/2018 07:26 | Nice to see the CEO almost doubling his ownership by market purchases here. | multiplural | |
15/7/2018 10:00 | Many thanks Someuwin ... on the way to pastures new! | hugus maximus | |
14/7/2018 11:52 | Share Information - as at 12th July 2018 (Web site recently updated) Edit: All mention of DMD has now been stripped out of the Summit web site & related costs will I guess follow soon & possible an update from Summit. | chrisatrdg | |
14/7/2018 09:42 | Many thanks Someuwin! | hugus maximus | |
13/7/2018 21:57 | well buy buy buy as gone ;) | football | |
13/7/2018 20:59 | Maybe Sarepta could be our saviour they have deep pockets & Summits current share price is a gift to them.I still believe that there could still be some value in the remaining DMD pipeline maybe a license deal.In summary I think we should still keep Sarepta in the picture to at least we have notice of Summits reorganisation.Just a thought. | chrisatrdg | |
13/7/2018 20:23 | ...Yup - I'll sort out the header later. | someuwin | |
13/7/2018 18:12 | send somewin a Private Message to mremove it, might work | football | |
13/7/2018 17:08 | Is there anybody who has the magic key to our misery and remove the rather irritating Sarepta share price chart from this BB!? Have a good weekend all. HM | hugus maximus | |
12/7/2018 21:45 | Despite looming resistance crisis, Novartis ducks out of antibiotics research Edit:A good read & shows what Summit is up against to get further traction on C-Diff. | chrisatrdg | |
11/7/2018 18:10 | Porn website very apposite for company developing anti-gonorrhoea drug. | vulgaris | |
11/7/2018 15:15 | Gosh! Its offering " back door" access too!! Don't think Mrs Trellis from Tunbridge Wells would be too amused..... Just when you think you really know someone...... | poseidon2 | |
11/7/2018 14:29 | chrisatrdg what you putting up a Porno site for? Nearly made me choke on my chocolate digestive | football |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions